Logo-apb
Adv Pharm Bull. 2023;13(1): 7-23. doi: 10.34172/apb.2023.009
PMID: 36721822        PMCID: PMC9871273

Review Article

What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review

Hanieh Abbasi 1,2 ORCID, Maryam Kouchak 2,3, Zohreh Mirveis 1,2, Fatemeh Hajipour 1, Mohsen Khodarahmi 1,2, Nadereh Rahbar 2 * ORCID, Somayeh Handali 4 * ORCID

Cited by CrossRef: 0


1- AbouSamra M. Liposomal nano-carriers mediated targeting of liver disorders: mechanisms and applications. Journal of Liposome Research. 2024;:1 [Crossref]
2- Paramshetti S, Angolkar M, Talath S, Osmani R, Spandana A, Al Fatease A, Hani U, Ramesh K, Singh E. Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions. Life Sciences. 2024;346:122616 [Crossref]
3- Gu Y, Jin L, Wang L, Ma X, Tian M, Sohail A, Wang J, Wang D. Preparation of Baicalin Liposomes Using Microfluidic Technology and Evaluation of Their Antitumor Activity by a Zebrafish Model. ACS Omega. 2024; [Crossref]